Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan Plans Incentives To Pharmacists To Push Generic Drugs (Japan)

This article was originally published in PharmAsia News

Executive Summary

Japan's health ministry plans to begin next April providing incentives to pharmacists to get them to push generic versions instead of brand-name drugs. An official says the government, as part of a medical cost-cutting effort, has drafted the plan to be included in a broader review of its medical service fee system. The incentive involves offering pay to pharmacists whose generics sales are at least 30 percent of the medicines they sell. The ministry expects health care spending to grow by 74 percent by 2025. (Click here for more ) "Japan Plans Generic Drug Incentives: Ministry" China Post (Taiwan) (12/7/07)

You may also be interested in...



Japan Looking To Western Countries For Generic Drug Utilization Tips

Japan's Ministry of Health, Labor and Welfare will send a research group to the U.S., U.K. and France in February, to study price setting and logistical systems being used in the pharmaceutical industries there, the MHLW announced Jan. 29.The research will focus on how to promote generic drugs in Japan to bring new ideas to the drug re-pricing discussions in April, said the MHLW

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.

Simplified Clinical Trial Transparency Rules To Go Live In The EU In June

A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules. 

Latest Headlines
See All
UsernamePublicRestriction

Register

SC065855

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel